Clinical Trial Update: Tamoxifen Prediction Study in Patients With ER+ Breast Cancer [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on tamoxifen prediction in ER-positive breast cancer patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Tamoxifen (tamoxifen)

Snippet

Sponsor: Erasmus Medical Center | Conditions: ER+ Breast Cancer | Phase 4 | Status: UNKNOWN